
The guidelines replace risk-based reccomendations for adults between 19-59 years.

Team-based care shows the reduction of multiple risk factors, attainment of multiple treatment targets, and empowerment among high-risk patients with DKD.

The costs related to Medicare for OACC increased by about 4% between 2012-2017 for patients with end-stage kidney disease for kidney transplantation.

When combined with corticosteroids, the oral therapy appeared to be as effective as IVCY with a more favorable safety profile.

A consensus was reached on nearly all proposals in the eDelphi study, which members said could be used to establish a clear dosing regimen for methotrexate.

The agency cited an increased risk of thromboembolic events driven by vascular access thrombosis in dialysis patients and increased risk of drug-induced liver injuries.

Males between 50-64 who have been vaccinated without erythema were at the highest risk of GBS.


Female academic ophthalmologists were paid a mean of $50,300 less than male peers.

Previously, few rapid diagnostic tests have been studied in home environments, and there are currently no tests approved for at-home influenza detection by the Food and Drug Administration (FDA)

The inaugural episode of Diabetes Dialogue features an introduction to hosts Diana Isaacs, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP, and Natalie Bellini, DNP, FNP-BC, and a discussion around recent regulatory news surrounding CGM devices in the US and Europe.

Headed to ACC.22 this weekend or following along virtually? Hear from Don't Miss a Beat co-hosts Drs. Vaduganathan and Greene on their top picks from the late-breaking sessions at the upcoming American College of Cardiology meeting.

Nearly all of the doctors polled recommended the pneumococcal vaccine for patients with cardiovascular disease aged 65 years and older.

Investigators conducted the largest study on SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses.

Dr. Bailey highlights the innovative nature of the procedure and breaks down the process at his institution.

The resolution of excess central retinal thickness in response to anti-VEGF therapy and the treatment burden were additionally similar between the 2 groups.

Human milk oligosaccharides could help treat some of the gut disruptions patients with depression often have.

Fecal microbiota transplantation is known to cure up to 88% of patients with recurrent C difficile infections.

Bristol Myers Squibb has to wait 3 months for FDA decision on Reblozyl for treating non-transfusion-dependent β-thalassemia.

The therapy is indicated for conditions associated with hypogonadism in adult males.

In a population aged 70 years and older, a remote history of VT was associated with an increased risk of VT independent of other factors.

A new AAD study shows board-certified experts produce only one-fourth of the most popular TikTok posts on subjects in their field.

With the newest indication, the GLP-1 agonist is now available in 3 different doses for diabetic adults.

An assessment of long-term VOYAGER 1 and 2 trial data show the IL-23 biologic provides significant benefit toward skin clearance, regardless of baseline characteristics.

The VALIANT study featured a cross-sectional online survey that was used to recruit adult patients 18 years and older who were professionally diagnosed with vitiligo.

Data from the ADhere studies found that lebrikizumab was well tolerated in patients with atopic dermatitis.

A pair of novel topical drugs hit high phase 3 marks at AAD 2022. One expert explains how they both may reach ground-breaking indications.

The lens is added to a patient’s eye through a quick surgical procedure with no removal of corneal tissue and can be removed by a doctor if desired.

Clinical responses including PASI 100 and absolute PASI, and PASI ≤2 were maintained through week 96 with the biologic in patients with psoriasis, with no new safety signals identified.

New AAD 2022 data support the novel gel therapy as the potentially first treatment for the viral-borne skin condition.